SCHEMBL11281993

SCHEMBL11281993

CCCc1cc2ccc(N)cc2c(CCC)c1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 2/20 0.37
▸ TLR7 Q9NYK1 1/20 0.37
▸ SREBF2 Q12772 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ KDM4E B2RXH2 6/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ HPGD P15428 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ CTDSP1 Q9GZU7 1/20 0.33
▸ SRC P12931 1/20 0.32
▸ ATM Q13315 2/20 0.32
▸ MEN1 O00255 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ HTT P42858 3/20 0.32
▸ HBB P68871 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ NT5E P21589 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11286481 0.87 SRC (0.35) TLR8TLR7SREBF2GPR84KDM4E
SCHEMBL28520283 0.74 TAAR1 (0.40) CYP3A4
SCHEMBL29987813 0.74 CYP19A1 (0.47) ALDH1A1ATMMAPK1TDP1CYP3A4
SCHEMBL3804549 0.73 NOS2 (0.36) KDM4EALDH1A1HPGDGAAHTT
SCHEMBL840292 0.69 NOS2 (0.33) KDM4EALDH1A1HSD17B10NOS2CASP7
SCHEMBL3802566 0.69 HTT (0.39) KDM4EALDH1A1MAPTHTTNOS2
SCHEMBL4576433 0.68 PRKCI (0.44) TLR8TLR7SREBF2KDM4EALDH1A1
SCHEMBL11700431 0.68 NOS2 (0.39) KDM4EALDH1A1HPGDGAANOS2
SCHEMBL3801329 0.68 KDM4E (0.39) KDM4EALDH1A1HTTNOS2POLB
SCHEMBL23050191 0.67 GAA (0.38) TLR8TLR7SREBF2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0055043-A2 6,7,8,9-Tetrahydro-3H-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives AYERST, MCKENNA AND HARRISON INC. (CA) 1982-06-30 — — EP disclosed
Send feedback